期刊文献+

原发性胆汁性肝硬化患者自身抗体、抗线粒体谱检测 被引量:5

下载PDF
导出
摘要 目的:分析自身抗体、血清酶谱、免疫球蛋白在原发性胆汁性肝硬化(PBC)诊断和鉴别诊断中的价值。方法:对48例PBC患者应用间接免疫荧光法(IIF)检测自身免疫性肝病9项指标,用免疫印迹法进行抗线粒体分型,应用生化法检测血清生化指标和免疫球蛋白。以40例肝炎肝硬化失代偿患者作对照。结果:48例PBC患者ANA、AMA和AMA-M2阳性率均明显高于对照组。血清ALP、γ-GT异常率高于对照组(P<0.05)。PBC患者免疫球蛋白增高以IgM为主。结论:PBC患者有胆汁淤积表现(血清ALP和γ-GT异常升高),有高滴度的ANA、AMA和AMA-M2抗体,这些表现有助于PBC的诊断和鉴别诊断。
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第2期358-359,共2页 Journal of Zhengzhou University(Medical Sciences)
  • 相关文献

参考文献11

  • 1贾继东.自身抗体检查在自身免疫性肝病诊断中的应用[J].中华检验医学杂志,2003,26(2):120-122. 被引量:40
  • 2Neuberger J.Primary biliary cirrhosis[J].Lancet,1997,350(9 081):875
  • 3Heathcote EJ.Management of primary biliary cirrhosis.The American association for the study of live diseases practice guidelines[J].Hepatology,2000,31(4):1 005
  • 4Lindor KD.Primary biliary cirrhosis:questions and promises[J].Ann Intern Med,1997,126(9):733
  • 5闫惠平,庄辉,刘燕敏,冯霞,檀玉芬,刘妍,张欣,赵春惠.原发性胆汁性肝硬化患者的免疫学特点分析[J].中华肝脏病杂志,2005,13(1):12-16. 被引量:49
  • 6Neuberger J,Thomson R.PBC and AMA--what is the connection[J].Hepatology,1999,29(1):271
  • 7Fussey S,Guest JR,James O,et al.Identification and analysis of the major MZ autoantigens in primary biliary cirrhosis[J].Proc Natl Acad Sci USA,1988,85(22):8 654
  • 8刘玉兰,肖文斌.原发性胆汁性肝硬化的研究进展[J].国外医学(消化系疾病分册),1998,18(3):167-169. 被引量:7
  • 9韩玉坤,张文瑾,陈菊梅,周华,王林杰.自身免疫性肝病临床与病理研究[J].中华肝脏病杂志,2001,9(S1):82-84. 被引量:11
  • 10Klein R,Pointner H,Zilly W,et al.Antimitochondrial antibody profiles in primary billiary cirrhosis distinguish at early stages between a benign and a progressive course:a prospective study on 200 patients followed for 10 year[J].Liver,1997,17(3):119

二级参考文献51

  • 1[1]Walker JG,Doniach D,Roitt IM,et al. Serological tests in the diagnosis of primary cirrhosis[J]. Lancet, 1965:827~830.
  • 2[2]Neuberger J. Primary biliary cirrhosis[J]. Lancet, 1997;350:875~879.
  • 3[3]Heathcote EJ. Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines [J ]. Hepatology, 2000; 31:1005 ~ 1013.
  • 4[4]Lindor KD. Primary biliary cirrhosis:questions and promises[J]. Ann Intern Med, 1997; 126: 733~ 735.
  • 5[5]Neuberger J,Thomson R. PBC and AMA-what is the connection? [J]. Hepatology,1999;29:271~276.
  • 6[6]Fussey S,Guest JR,James O,et al. Identification and analysis of the major M autoantigens in primary biliary cirrhosis[J].Proc Natl Acad Sci USA, 1988; 85 : 8654 ~ 8658.
  • 7[7]Klein R,Berg PA. Significance of antimitochondrial antibody profiles in primary biliary cirrhosis. In:Lindon KD,Heathcote EJ, Poupon R, eds. Primary biliary cirrhosis: From pathogenesis to clinical treatment [M]. Dordrecht, Netherland, Kluser Academic Pub, 1998: 24 ~ 34.
  • 8[8]Bassendine MF,Jones DE,Yeaman SJ. Biochemistry and autoimmune response to the 2-oxyacid dehydrogenase complexes in primary biliary cirrhosis [J]. Sernin Liver Dis, 1997;17:49~60.
  • 9[9]Sherlock S. Dooley J. Diseases of the liver and biliary system[M]. 11 th ed. Oxford UK, Blackwell Science, 2002 : 242.
  • 10[10]Zein CO. Boe GM. Donlinger J. et al. The role of liver biopsy in diagnosis of primary biliary cirrhosis [J]. Hepatology,2001; 34: 343.

共引文献98

同被引文献41

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部